A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. [electronic resource]
Producer: 20140610Description: 2083-92 p. digitalISSN:- 1533-4406
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Antifibrinolytic Agents -- adverse effects
- Disease Progression
- Double-Blind Method
- Enzyme Inhibitors -- administration & dosage
- Female
- Humans
- Idiopathic Pulmonary Fibrosis -- drug therapy
- Male
- Middle Aged
- Pyridones -- adverse effects
- Treatment Outcome
- Vital Capacity -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.